The $191M figure is the headline, but the $27.3M slice to Pacific Scientific is the operative constraint. Chandler is already running near nameplate capacity for tactical SRM production. Expanding it requires not just tooling and facility upgrades but sustained labor availability in a tight Arizona manufacturing market.
If this $27.3M enables Pacific Scientific to add 20-30% throughput, Dark Eagle production can sustain a 2-3 unit-per-month cadence through 2027. If it's a smaller increment (10-15%), the program will face either delivery delays or competition for SRM inventory with other hypersonic and tactical missile programs (AGM-183 ARRW, RIM-174 variants, air-launched cruise missile derivatives).
Solid rocket motors are the irreplaceable propulsion backbone for tactical missiles, strategic systems, and hypersonic glide bodies — and the industrial base has been a persistent bottleneck.
This $27.3M tranche to Pacific Scientific (one of two primary domestic SRM suppliers alongside Northrop Grumman Space Systems) signals the Pentagon is moving beyond rhetoric into concrete capacity bets. The timing matters: the Army just awarded GDN Leidos $2.7B for Dark Eagle C-HGB production (May 14), and that program will consume SRM throughput immediately.
If Pacific Scientific's Chandler facility can absorb this capital and translate it into higher production rates by late 2026, the Dark Eagle deployment timeline holds. If the facility hits the same labor and supply-chain friction that has plagued other advanced manufacturing restarts, Dark Eagle moves right.
What is the actual production capacity increase Pacific Scientific expects from this $27.3M investment — units per year or total annual throughput? Does the $191M total include commitments to other SRM suppliers (Northrop, Orbital ATK, or newer entrants), and if so, how is the capital allocated?
Strategic intelligence, synthesized daily — with a public track record. Every call graded against what actually happened.